Poland· PL-100334502

Soltopin

A mupirocin product containing mupirocinum, registered in Poland by Infectopharm Arzneimittel und Consilium GmbH. The same ATC class is registered in 15 of our 19 countries.

ATC D06AX09

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about mupirocinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Mupirocin is registered in 15 of 19 countries.

Countries holding a registration under ATC D06AX09 (mupirocin), each read from that country’s own register.

This record: Poland, from URPL (Poland)
8 of them publish a price we can compare per daily dose

Search mupirocin products by name

Mupirocin · ATC D06AX09

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mupirocin costs, country by country.

Normalised to the WHO defined daily dose (40 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Mupirocin · price per daily dose (40 mg)

USD · FX 28 Sept 2026

CZ Czechia$0.0011

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Mupirocinum
Manufacturer: Infectopharm Arzneimittel und Consilium GmbH
Country: Poland (PL)
ATC code: D06AX09
ATC class: Mupirocin
Defined daily dose: 40 mg, T
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 5

gtin
05909991272166
gtin
05909991272173
gtin
05909991272159
gtin
05909991272180
gtin
05909991272197

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

151 interactions on record for mupirocin.

Graded by severity as the source publishes them — 151 info. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check mupirocin against other medicines How interaction checks work

Mupirocin · interactions on record

151 records

151 info

Most severe, free to view

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Mupirocin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mupirocin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Bactroban, Infectopyoderm
Belgium · Bactroban
Bulgaria · Бактробан, Мупиродермал
Cyprus · Bactroban, Mupiderm
Czechia · Bactroban, Bactroban Nasal
Germany · Infectopyoderm, Mupirocin Infectopharm
Denmark · Bactroban
Spain · Bacnas, Bactroban
Finland · Bactroban Nasal
France · Bactroban, Mupiderm
United Kingdom (Northern Ireland) · Bactroban, Mupirocin Aspire Pharma
Greece · Bactroban, Bactrocine
Croatia · Betrion, Mirobact
Hungary · Bactroban, Mupirocin Infectopharm
Ireland · Bactroban
Iceland · Bactroban, Bactroban Nasal
Italy · Bactroban, Bactroban Nasale
Luxembourg · Bactroban
Latvia · Munipix
Malta · Bactroban, Mupironasal
Netherlands · Bactroban, Bactroban Huidzalf
Portugal · Bactroban, Impetine®
Sweden · Bactroban, Bactroban Nasal
Slovenia · Betrion
Slovakia · Bactroban

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bf97439e-fc04-4585-b98b-b47c1a5cd1d5
GET /v1/drugs/bf97439e-fc04-4585-b98b-b47c1a5cd1d5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Maść",
  "source": "urpl",
  "strength": "20 mg/g",
  "packaging": "05909991272159 ¦ Rp ¦ 115264\n1 tuba 15 g\n05909991272166 ¦ Rp ¦ 115265\n1 tuba 5 g\n05909991272173 ¦ Rp ¦ Skasowane ¦ 115266\n2 tuby 5 g\n05909991272180 ¦ Rp ¦ Skasowane ¦ 115267\n2 tuby 15 g\n05909991272197 ¦ Rp ¦ Skasowane ¦ 115268\n3 tuby 5 g",
  "substance": "Mupirocinum 2.2 g/100 g",
  "common_name": "Mupirocinum",
  "pl_product_id": "100334502",
  "pozwolenie_nr": "23118",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about mupirocin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console